Nicolaas de Vries, MD, PhD

Effects of Solriamfetol on Driving Performance in Participants With Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea

Introduction: Solriamfetol, a dopamine/norepinephrine reuptake inhibitor, is approved (US and EU) to treat excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA;...

Johannes Ramaekers , PhD;

Annemiek Vermeeren , PhD;

Jerryll Asin , MD;

Nicolaas de Vries , MD, PhD;

Patty Vonk , MD;

Claire Donjacour , MD, PhD;

Hennie Janssen , MD, PhD;

Dandan Chen , MD, PhD;

Frederick Vinckenbosch , MSc;

Gert Jan Lammers , PhD, MD;

Sebastiaan Overeem , MD, PhD;

Grace Wang , MD, MS;

Lawrence Carter , PhD;

Kefei Zhou , PhD;

10/08/2020

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Nicolaas de Vries, MD, PhD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products